RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer. PUBLISHED: OCTOBER 18, 2016. Be the first to discuss this article on CURE's forum.
FDA Approves Repatha (evolocumab) Pushtronex - First And Only Single Monthly Injection for a PCSK9 Inhibitor: Aug 27, 2015: FDA Approves Repatha (evolocumab) to Treat Certain Patients with High Cholesterol: Apr 29, 2015: Amgen Announces FDA Advisory Committee Meeting to Review Repatha (Evolocumab) for High Cholesterol: Mar 15, 2015